Is bicarbonate therapy effective in preventing CKD progression?

Area of Science:

• Nephrology
• Internal Medicine
• Pharmacology

Background:

• Chronic kidney disease (CKD) is a progressive condition affecting millions worldwide.
• Maintaining renal function and delaying end-stage renal disease (ESRD) are key therapeutic goals in CKD management.
• Acidosis is a common complication in CKD, and sodium bicarbonate is a potential therapeutic agent.

Purpose of the Study:

• To evaluate the efficacy of sodium bicarbonate therapy in slowing renal function loss in CKD patients.
• To assess the impact of sodium bicarbonate on the progression to end-stage renal disease (ESRD).

Main Methods:

• A meta-analysis of lower-quality randomized controlled trials (RCTs) was conducted.
• The study analyzed data from trials investigating sodium bicarbonate therapy in patients with CKD.
• Secondary analyses examined the effect of therapy duration.

Main Results:

• Long-term sodium bicarbonate therapy demonstrated a slight slowing of renal function loss in CKD patients (SOR: B).
• The therapy may moderately reduce the progression to end-stage renal disease (SOR: B).
• Therapy durations of one year or less did not show significant benefits (SOR: C).

Conclusions:

• Long-term sodium bicarbonate therapy is recommended for patients with chronic kidney disease to preserve renal function.
• The findings suggest a potential role for sodium bicarbonate in delaying the need for dialysis or transplantation.
• Further research with higher-quality RCTs is warranted to confirm these benefits and optimize treatment duration.